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Dysregulation of Protein Kinase A Signaling
in the Aged Prefrontal Cortex: New Strategy
for Treating Age-Related Cognitive Decline
functions dependent on the amygdala and posterior cor-
tices (Barros et al., 2000; Huang et al., 2000; Schafe and
LeDoux, 2000).
PKA activity can also be increased through the sys-
temic administration of agents that inhibit phosphodies-
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terase (PDE) activity, thus preventing the breakdown ofYale University School of Medicine
cAMP. Toledo-Morrell first showed that the PDE inhibi-New Haven, Connecticut 06510
tor, pentoxifylline, improved hippocampal function in
aged rats (de Toledo-Morrell et al., 1984). More recently,
research has focused on rolipram, a selective inhibitorSummary
of type 4 cyclic AMP phosphodiesterase (PDE4), which
elevates levels of cAMP in vivo (Randt et al., 1982).Activation of the cAMP/protein kinase A (PKA) path-
Based on the studies reviewed above, rolipram wasway has been proposed as a mechanism for improving
tested in animals with long-term memory impairment.age-related cognitive deficits based on studies of hip-
Rolipram improved long-term memory consolidationpocampal function. However, normal aging also af-
and facilitated LTP in aged mice (Barad et al., 1998) andflicts prefrontal cortical cognitive functioning. Here,
reversed the memory deficits induced in young rats thatwe report that agents that increase PKA activity impair
were injected with either a muscarinic receptor antago-rather than improve prefrontal cortical function in aged
nist (Imanishi et al., 1997; Zhang and O’Donnell, 2000),rats and monkeys with prefrontal cortical deficits.
an NMDA receptor antagonist (Zhang et al., 2000), or aConversely, PKA inhibition ameliorates prefrontal cor-
protein synthesis inhibitor (Randt et al., 1982). Thus,tical cognitive deficits. Western blot and immunohisto-
there is a highly consistent literature demonstrating thatchemical analyses of rat brain further indicate that
PKA activation enhances the long-term memory func-the cAMP/PKA pathway becomes disinhibited in the
tions of posterior cortical and subcortical structuresprefrontal cortex with advancing age. These data dem-
such as the hippocampus. Based on this research inonstrate that PKA inhibition, rather than activation, is
rodents, various pharmaceutical companies are devel-the appropriate strategy for restoring prefrontal corti-
oping agents that enhance PKA activation as a treat-cal cognitive abilities in the elderly.
ment for age-related cognitive decline in humans (Lan-
greth, 2002).Introduction
Although most basic research in rodents has focused
on hippocampal mechanisms, deficits in prefrontal cor-The human population’s average life span has increased
tex function are prominent with advancing age, particu-dramatically over the last century. Consequently, the
larly in human and nonhuman primates. The prefrontalnumber of individuals living with diminished cognitive
cortex guides behavior and thought using working mem-capabilities due to the aging process has also increased.
ory (Goldman-Rakic, 1987) and plays an increasinglyThus, it is imperative to meet the growing demands for
important role in the cognitive behavior of primates. Thetreatments aimed at age-related cognitive decline and
prefrontal cortex is engaged during the retrieval andto understand fundamental cellular and intracellular
encoding of memories (especially if it is an effortful pro-changes that emerge in the aging brain (Colombo et
cess) and is critical for inhibition of proactive interfer-al., 1997).
ence, for protecting memories and thoughts from dis-
Activation of the cAMP/protein kinase A (PKA) intra-
traction, and for allowing us to plan and organize
cellular signaling pathway has been proposed as an
behavior (Bunge et al., 2001; Kapur et al., 1995; Lepage
avenue for the clinical treatment of age-related deficits et al., 2000; Stuss and Knight, 2002). Normal aging con-
in human memory (Barad et al., 1998). Studies of long- sistently impairs many of the cognitive functions of the
term memory consolidation in hippocampus support prefrontal cortex in humans, monkeys, and rats (Albert,
this idea. Aged animals and humans exhibit deficits in 1997; Ando and Ohashi, 1991; Bartus et al., 1978; Bi-
memory consolidation linked to hippocampal function monte et al., 2003; Chao and Knight, 1997; Herndon et
(Gallagher and Rapp, 1997; Herndon et al., 1997). Ge- al., 1997; Nielsen-Bohlman and Knight, 1995; Rapp and
netic (Abel et al., 1997; Rotenberg et al., 2000) and phar- Amaral, 1989; Schacter et al., 1996; West, 1996). Impor-
macological (Barros et al., 2000; Bernabeu et al., 1997; tantly, neuropharmacological studies indicate that the
Bourtchouladze et al., 1998; Frey et al., 1993) inhibition prefrontal cortex is modulated very differently than the
of PKA (e.g., with Rp-cAMPS) can disrupt long-term hippocampus and thus would require different treatment
potentiation (LTP) in the hippocampus and/or impair strategies. For example, in contrast to the hippocampus
long-term memory consolidation, whereas activation of and posterior cortical areas, infusion of the PKA activa-
PKA (e.g., with Sp-cAMPS) can induce LTP and enhance tor, Sp-cAMPS, directly into the prefrontal cortex im-
memory consolidation (Bernabeu et al., 1997; Frey et pairs working memory function in young adult rats (Tay-
al., 1993; Huang and Kandel, 1998). Activation of the lor et al., 1999).
cAMP/PKA pathway also enhances long-term memory The current study examined how treatments that alter
PKA activation influence prefrontal cortical functions in
aged animals. PKA activity was directly activated or*Correspondence: amy.arnsten@yale.edu
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inhibited in the rat prefrontal cortex using Sp-cAMPS or
Rp-cAMPS, respectively, similar to previous studies in
young rats (Taylor et al., 1999). Rats were tested on the
delayed alternation task in a T-maze, a test of spatial
working memory that is impaired by lesions to the pre-
limbic/infralimbic prefrontal cortex in rats (Divac, 1971).
A parallel study examined the effects of PKA activation
in young versus aged monkeys performing a spatial
working memory task, delayed response. As Sp-cAMPS
and Rp-cAMPS do not penetrate the blood-brain barrier
when given systemically, the monkeys were injected
with the PDE4 inhibitor, rolipram, similar to previous
research in rodents (Barad et al., 1998; Imanishi et al.,
1997; Randt et al., 1982; Zhang and O’Donnell, 2000).
Western blot analysis was performed on prefrontal cor-
tex, hippocampus, and cerebellum of aged versus young
adult rats to characterize age-related changes in the
cAMP-PKA signaling pathway. Two AC isoforms were
examined, AC2 and AC3. The regulatory and catalytic
subunits of PKA and the phosphodiesterase isoforms
PDE4a, PDE4b, and PDE4d were measured, as well as
indirect measures of PKA activity, cAMP response ele-
ment binding protein (CREB), and CRE binding. Activa-
tion of the cAMP/PKA pathway has been shown to
upregulate CREB expression through CRE binding in a
Figure 1. Localization of Infusion Sites in the Prefrontal Cortex ofnumber of cell types (Coven et al., 1998). Finally, phos-
Aged Ratspho-CREB immunohistochemistry was performed on rat
Black dots within the brain slices show the sites of bilateral infusionsprefrontal cortex and hippocampus to provide a more
using guide cannula. The infusion cannula tips were located dorsaldirect measure of PKA activity. The findings from both
to the medial prefrontal cortex in the prelimbic region (stereotaxic
the behavioral and biochemical studies suggest that coordinates: anterioposterior, 3.2 mm; mediolateral, 0.75 mm;
the cAMP/PKA pathway becomes disinhibited in the dorsoventral, 4.2 mm).
prefrontal cortex with advancing age and contributes to
loss of prefrontal cortical cognitive function.
cAMPS dose was selected based on previous work in
young rats, which had shown that 21 nmol/0.5 l Sp-Results
cAMPS significantly impaired performance, whereas
0.21 and 2.1 nmol/0.5 l had no effect (Taylor et al.,Rats
Young adult (9 months) and aged (approximately 24 1999). The Rp-cAMPS dose was based on a pilot study,
in which young and aged rats were examined after amonths when tested) rats were surgically implanted with
guide cannula directed above the prefrontal cortex (Fig- wide range of Rp-cAMPS concentrations (0.021, 0.21,
2.1, 21, 42, and 84 nmol/0.5 l). In young rats, no doseure 1). Animals were trained on a delayed alternation
task in the T-maze, a test of spatial working memory that of Rp-cAMPS had any effect, with the exception that
impairment was found at the highest dose (84 nmol:depends upon the functional integrity of the prefrontal
cortex (Divac, 1971). Delays began at “0” seconds (s) 51.9%  7% correct, p  0.031 compared to vehicle).
Seizures were observed in some animals following thisand were gradually raised in 5 s intervals throughout
the drug study as the animal performed 80% correct high dosage; thus, the relevance to cognitive function
remains in question. No dose of Rp-cAMPS impairedon consecutive days (see Experimental Procedures).
Thus, the number of sessions to achieve a delay of 15 the aged rats, including the 84 nmol dosage (62.5% 
7.3% correct, p  0.45 compared to vehicle). Pilot stud-s can be used to characterize the cognitive ability of the
animal performing the task. Young adult rats (n  26) ies indicated that the 2.1 nmol/0.5 l Rp-cAMPS dose
improved performance in aged rats; thus, this dose be-required an average of 26.7  3.7 testing sessions to
achieve a 15 s delay, while aged rats (n  15) required came the focus of the current study (see below). Given
the fragility of the aged animals and thus the limitedan average of 49.9  8.4 testing sessions (p  0.004,
unpaired t test). There was great variability in this mea- number of infusions that could be done in this age group,
we focused on the 2.1 nmol/0.5 l dose for both Rp-sure within the aged group, with some animals per-
forming as well as the young, and others much impaired cAMPS and Sp-cAMPS in the current research.
The effects of 2.1 nmol/0.5l Sp-cAMPS and 2.1 nmol/(see x axis in Figures 2A and 2B).
Once the rats were performing in a stable manner 0.5l Rp-cAMPS in aged rats depended upon the cogni-
tive status of the animal (Figures 2A and 2B). As shown(see Drug Infusions in Experimental Procedures), PKA
signaling in the prefrontal cortex was manipulated prior in Figure 2A, the greater the number of test sessions
needed to achieve a 15 s delay, the greater the impair-to testing by infusing either the PKA activator Sp-cAMPS
or the PKA inhibitor Rp-cAMPS into the prefrontal cor- ment following infusion of Sp-cAMPS into the prefrontal
cortex. In other words, the greater the cognitive deficittex. Results were compared to vehicle infusion. The Sp-
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This effect was not simply an artifact of the delay length
used in the task, as Rp-cAMPS did not improve the
aged, cognitively intact rats even when it was adminis-
tered when delay intervals were short. Correlational
analyses showed no significant relationship between
delay interval and response to either drug. Rather, the
response to the drug depended on the overall prefrontal
cortical abilities of the aged rat. In contrast to aged
animals, there was no correlation between cognitive sta-
tus and the response to 2.1 nmol Rp-cAMPS (r0.065,
ns) or 2.1 nmol/0.5l Sp-cAMPS (r  0.21, ns) in young
adult rats. Interestingly, in aged rats there was a signifi-
cant correlation between the degree of impairment in-
duced by 2.1 nmol/0.5 l Sp-cAMPS and the amount of
improvement seen when infusing 2.1 nmol/0.5 l Rp-
cAMPS in the same aged animal (n 11, Pearson’s test:
r  0.76, p  0.01, Figure 2C). In other words, the
more an aged rat was impaired by Sp-cAMPS, the more
it was improved by Rp-cAMPS. These results contrast
with studies in the hippocampus and posterior cortex,
where Sp-cAMPS improves rather than impairs memory
performance, providing more support for the idea that
the prefrontal cortex is regulated differently than other
brain regions.
Monkeys
Sp-cAMPS and Rp-cAMPS do not cross the blood-brain
barrier, and thus cannot be administered systemically.
However, the PDE4 inhibitor, rolipram, is capable of
penetrating the brain following systemic administration
and has been shown to enhance long-term memory con-
solidation in aged mice (Barad et al., 1998). Thus, roli-
Figure 2. PKA Manipulation in the Prefrontal Cortex and Its Effects
pram was administered to young adult (4–18 years,on Working Memory Performance in Aged Rats
n  7) and aged (18–30 years, n  7) rhesus monkeys,Dashed lines represent the mean performance under vehicle in-
1 hr prior to cognitive testing on the spatial delayedfusion.
response task. Performance of this spatial working(A) Correlation between percent correct during working memory
task after PKA activation using 2.1 nmol/0.5 l of Sp-cAMPS (y axis) memory task is dependent on the integrity of the dorso-
and testing sessions needed to achieve a 15 s delay (x axis). The lateral prefrontal cortex (Goldman-Rakic, 1987) and is
impairing effects of PKA activation (Sp-cAMPS) were greater in the consistently impaired by normal aging in rhesus mon-
rats that needed more than 40 test sessions to achieve 15 s delays
keys (Bartus et al., 1978; Rapp and Amaral, 1989). Within(p  .01, n  13).
each test session, performance was assessed across a(B) Correlation between percent correct during working memory
variety of delay lengths, ranging between a 0 s delaytask after PKA inhibition using 2.1 nmol/0.5 l of Rp-cAMPS (y axis)
and testing sessions needed to achieve a 15 s delay (x axis). The control condition and the delay where each monkey
enhancing effects of PKA inhibition (Rp-cAMPS) were greater in the performed at chance (50%). Three intermediate delay
rats that needed more than 40 test sessions to achieve 15 s delays intervals were also used so that drug effects could be
(p  .01, n  11).
examined across the span of each monkey’s abilities.(C) Correlation between the percent correct following 2.1 nmol/0.5
A wide rolipram dose range was examined in all animals:l of Rp-cAMPS (y axis) and the percent correct following 2.1 nmol/
0, 0.01, 0.1, 1.0, 10.0, 50, or 100 g/kg was administered0.5 l of Sp-cAMPS (x axis) in the aged rats who had received both
treatments (n  11). The animals that were impaired by Sp-cAMPS in random order with at least 1 week washout between
were those that were improved by Rp-cAMPS (r  76, p  0.01). doses. As side effects of agitation and drooling were
Note that the animals received these treatments on different test- observed at doses 50 g /kg, only the 0, 0.01, 0.1, 1.0,
ing sessions.
and 10.0 g/kg doses were used for analyses of effects
on cognitive performance.
Rolipram had a significant effect on delayed responsedue to age, the more impaired the rat was during the
testing session following an acute activation of PKA performance (significant within subjects effects of roli-
pram: F(4,48) 3.42, p 0.015], but its effects on perfor-(significant correlation between days to achieve 15 s
delay and response to Sp-cAMPS: r  0.78; p  0.01, mance were dependent upon the age of the animal [sig-
nificant between subjects effects of age: F(1,12) 4.99,Pearson’s test). Conversely, the greater the cognitive
deficit due to age, the more the rats were improved by p 0.045]. As can be seen in Figure 3A, young monkeys
tended to be improved by the 0.1g/kg dose of rolipramPKA inhibition with Rp-cAMPS (r 0.70; p 0.01, Figure
2B). Therefore, the aged animals that needed prefrontal [F(1,6)  4.94, p  0.068]. However, this finding did not
reach statistical significance due to the great variabilitycortical cognitive enhancement the most were improved
by inhibition rather than activation of the PKA pathway. in individual response to rolipram (SEM  4.7% for roli-
Neuron
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rolipram’s effects on performance at each delay length
confirmed this interpretation (effect of delay [F(4,20) 
5.048, p  0.006]; effect of rolipram [F(1,5)  12.411,
p  0.017]). Rolipram did not increase errors following
the 0 s delay control condition [F(1,5) 1.840, p 0.233]
but did impair performance following intermediate de-
lays when the prefrontal cortex was needed to guide
behavior [F(1,5)  8.67, p  0.032 and F(1,5)  15.21,
p 0.011]. There was no further impairment by rolipram
at the longest delays, as the aged monkeys were per-
forming at chance levels under these conditions follow-
ing saline administration [F(1,5) 0.044, p 0.840]. The
interaction of advancing age with response to rolipram
was also evident in a correlational analysis: there was
a significant correlation between estimated age of the
monkey and the degree of impairment induced by 10.0
g/kg rolipram (Figure 3C; Spearman test: r  0.579,
p 0.03). Thus, in contrast to rolipram’s beneficial influ-
ence on hippocampal-dependent memory functions in
aged mice, rolipram impaired working memory perfor-
mance in aged monkeys.
Age-Related Changes in the PKA Pathway
In an effort to understand the underlying mechanisms
involved in the differential response to PKA manipula-
tions with age, young versus aged rat brains were com-
pared using Western analyses and immunohistochemis-
try. Three regions of the brain associated with learning
and memory were examined: the prefrontal cortex, hip-
pocampus, and cerebellum. Basal PKA levels (regula-
tory or catalytic subunit immunoreactivity in all brain
regions examined) were not affected by age (data not
shown). Similarly, there were no age-related changes in
PDE4a, PDE4b, or PDE4d (data not shown). Previous
evidence had suggested that the AC system, which is
upstream of PKA, may be more vulnerable to age, partic-Figure 3. Effects of a Systemic Administration of the PDE4 Inhibitor,
ularly in the cerebral cortex, hippocampus, and cerebel-Rolipram, on the Working Memory Performance of Young versus
Aged Monkeys lum (Araki et al., 1995, 1997). Therefore, immunoblot
assays examined basal levels of AC2 and AC3 isoforms(A) The effects of rolipram in young adult monkeys (n 7). Rolipram
had no effect in the young monkeys performing a delayed response in young versus aged rats (Table 1). Proteins down-
task, except at a dose of 0.1 g/kg, where it tended to improve stream of cAMP/PKA signaling, CREB and CRE binding,
performance. Data represent the number of trials correct out of 30 were also assessed as an indirect measure of PKA activ-
(y axis) and increasing dose of rolipram (x axis). Dashed lines delin-
ity. Finally, a separate immunohistochemical study as-eate the range of number correct under vehicle injection.
sessed numbers of phospho-CREB-positive cells in pre-(B) The effects of rolipram in aged monkeys (n  7). In contrast to
frontal cortex and hippocampus as a direct measure ofthe young monkeys, aged monkeys showed no improvement and
were impaired at a 10 g/kg dose of rolipram. Data represent the PKA activity in young versus aged rats performing a
number of trials correct out of 30 (y axis) and increasing dose of working memory task.
rolipram (x axis). Dashed lines delineate the range of number correct In the prefrontal cortex, AC3 tended to be reduced but
under vehicle injection.
was not significant due to the high degree of variability in(C) Correlation between rank order of the age of monkeys (x axis,
the young animals (p  0.2; Table 1). No significantn  14) and the degree of impairment (y axis, performance shown
reduction in AC2 was found (p  0.67; Table 1). Asas percent change from vehicle) induced by 10.0 g/kg rolipram
(r  0.579, p  0.03). shown in Figure 4A, CREB immunoreactivity tended to
be increased (p  0.08) and CRE binding was signifi-
cantly higher in the aged prefrontal cortex (p  0.006).
In the hippocampus, AC3 immunoreactivity was sig-pram compared to SEM  1.4% for saline). In contrast,
aged animals showed no improvement with any dose of nificantly reduced in aged versus young rats (p  0.02;
Table 1). As in the prefrontal cortex, there was no changerolipram, and performed significantly worse than saline
performance following the 10.0 g/kg dose [Figure 3B; in AC2 (p 0.56; Table 1). However, unlike the prefrontal
cortex, there was no change in CREB levels (p  0.74)F(1,6)  13.00, p  0.011]. There was no evidence of
side effects at this dose (median sedation score of 0, or in the amount of CRE binding (p  0.26) (Figure 4A).
Finally, in the cerebellum of aged rats, there was nonormal behavior), suggesting that impairment arose
from altered cognitive ability rather than from nonspe- change found in the levels of AC isoforms (p 0.7; Table
1). Similar to the hippocampus, there was no change incific effects on performance. An analysis of 10.0 g/kg
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Table 1. Basal Levels of Adenylyl Cyclase Isoforms AC2 and AC3 in Young versus Aged Rats as Percent of Young Controls
Prefrontal Cortex Hippocampus Cerebellum
AC Isoform Young Aged Young Aged Young Aged
AC2 100  15a 90  18 100  8 92  11 100  18 109  17
AC3 100  11 81  6 100  7 83  5b 100  4 101  8
a Data presented as mean  SEM.
b Significantly different from young.
CREB levels (p  0.35) or in the amount of CRE binding CREB in the nucleus (Gonzalez and Montminy, 1989).
As levels of phospho-CREB are a direct measure of PKA(p  0.9) (Figure 4A). Thus, none of the measures were
different in the aged cerebellum. activity, we examined the number of cells staining for
phospho-CREB in aged versus young rats performingOverall, these results suggest that the prefrontal cor-
tex may be affected differently than these other brain the delayed alternation task immediately prior to sacri-
fice. All but one of the aged rats showed impaired perfor-regions by the aging process, as evidenced by the in-
creased CRE binding and trend for increased CREB mance on the delayed alternation task, achieving an
average delay of only 3.3 s at time of sacrifice. As islevels in aged prefrontal cortex tissue. The increase in
CRE binding may indirectly reflect increased PKA activa- shown in Figure 5, aged rat prefrontal cortical tissue had
a significantly higher number of cells immunostained fortion since activation of this pathway has been shown
to upregulate CRE-mediated gene expression including phospho-CREB compared to young prefrontal cortex
(p  0.003, unpaired t test). Furthermore, the intensitythe CREB gene itself (Coven et al., 1998).
The catalytic subunit of PKA directly phosphorylates of the staining (indicative of the amount of phospho-
CREB present within each cell) was higher in the aged
than in the young prefrontal cortex (Figure 6, upper
panel). In contrast, aged hippocampal tissue had a
slightly lower number of cells that were phospho-CREB
immunoreactive (Figure 5), but this difference was not
significant (mean aged  154.4; mean young  161.4;
p  0.553). The cells from aged hippocampal sections
stained less darkly than the cells from the young hippo-
campus (Figure 6, lower panel), consistent with less PKA
activity within each cell in the aged hippocampus. Thus,
the prefrontal cortex and hippocampus showed oppo-
site profiles with advancing age: the prefrontal cortex
showed indices of increased PKA activity, while the hip-
pocampus exhibited evidence of decreased PKA ac-
tivity.
Discussion
The working memory functions of the prefrontal cortex
are regulated differently than hippocampus and poste-
rior cortical regions. Thus, activation of intracellular sig-
naling pathways that strengthen memory consolidation
in hippocampus impair the working memory functions
of the prefrontal cortex (Birnbaum et al., 1999; Taylor et
al., 1999). For example, infusions of the PKA activator,Figure 4. Age-Related Changes in Levels of CREB and CRE Binding
in Brain Regions Associated with Learning and Memory Sp-cAMPS, into the hippocampus enhances memory
consolidation (Bernabeu et al., 1997), while infusion in(A) Graphs show the mean percent change of CREB immunoreactiv-
ity and CRE binding in the brain extracts of aged (black bars; n  the prefrontal cortex impairs working memory perfor-
6) compared to young (white bars; n  6) rats in prefrontal cortex mance (Taylor et al., 1999). In the hippocampus, PKA
(PFC), hippocampus (HIP), and cerebellum (CER). Asterisks highlight activation is thought to keep memory fixed and enhance
the significant age-related changes in these different brain regions.
long-term storage of information. In contrast, the pre-CREB represents the immunoreactivity of CREB protein as assessed
frontal cortex may be especially vulnerable to disinhibi-by Western blot analysis. CRE represents the amount CRE binding
tion of the PKA pathway, given the great need for erasuredetermined by gel shift analysis. The MR value observed for CREB
was approximately 46 kDa (upper band), which is consistent with in the updating of working memory. Until now, research
previous published values. Actual bands from prefrontal cortical has focused on activating PKA to strengthen hippocam-
tissue are shown at the top of (A) in alignment with the corresponding pal function and improve memory in aged subjects.
bars underneath. However, no research has examined the consequences
(B–D) Specificity of CRE binding in prefrontal cortical tissue. This
of activating PKA in the prefrontal cortex with advancingincludes supershift of CRE binding by preincubation with CREB
age, despite the prevalence of prefrontal cortical cogni-antibody (B) and displacement by unlabeled CRE (0 to 100 ng) (C),
but not a mutated CRE oligonucleotide (D). tive deficits in the elderly.
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hippocampus. As all but one of the aged rats showed
impaired performance on the delayed alternation task,
future studies will be needed to compare phospho-
CREB staining in cognitively intact versus impaired aged
rats. Taken together, these data indicate that PKA sig-
naling in the prefrontal cortex becomes disinhibited with
advancing age and that further stimulation of this path-
way, even with a very low dose of an activator such as
Sp-cAMPS, exacerbates cognitive deficits. Conversely,
a very low dose of the PKA inhibitor, Rp-cAMPS, was
sufficient to ameliorate cognitive impairment in aged
rats. These data indicate that the cAMP/PKA signaling
pathway becomes disinhibited within prefrontal cortical
neurons with advancing age and that relatively subtle
manipulations of this pathway can have marked effectsFigure 5. Number of Cells Staining Positive for Phospho-CREB in
Young versus Aged Prefrontal Cortex and Hippocampus on prefrontal cortical cognitive functioning in aged an-
Graphs show the mean  SEM number of cells (y axis) immuno- imals.
stained for phospho-CREB in the prefrontal cortex (PFC) and hippo- The results in monkeys provide additional support for
campus (HIP) (x axis). Black bars depict the data from aged rats, this hypothesis and extend these findings to primates.
while white bars depict the data from young rats. *p  0.003.
Systemic administration of rolipram, which indirectly in-
creases PKA activity, had little effect in young monkeys
but impaired the prefrontal cortical cognitive perfor-The current study provides the first behavioral and
mance of aged monkeys following the 10 g/kg dose.biochemical characterization of cAMP/PKA signaling in
The detrimental effects of rolipram in the aged monkeysthe aged prefrontal cortex. Cognitive studies revealed
appeared to represent deficits in prefrontal cortical cog-that aged rats with prefrontal cortical cognitive deficits
nitive function rather than nonspecific impairment duewere more sensitive to both the impairing effects of PKA
to side effects, as there was no increase in errors underactivation and the enhancing effects of PKA inhibition.
0 s delay control conditions and no change in behavioralMolecular analyses supported this conclusion. Western
ratings at this dose. Interestingly, the magnitude of theanalyses showed evidence for disinhibition of basal
impairment correlated with increasing age, consistentcAMP/PKA signaling in the aged prefrontal cortex, but
with progressive disinhibition of PKA signaling with ad-not in other brain regions examined. This hypothesis
vancing age. These results in aged monkeys are oppo-was confirmed in an immunohistochemical analysis of
site to what was found with rolipram administration inphospho-CREB staining in the prefrontal cortex and hip-
aged mice, who were improved following systemic roli-pocampus of young versus aged rats performing a work-
pram administration (Barad et al., 1998). This discrep-ing memory task. Phospho-CREB staining was in-
creased in the aged prefrontal cortex but not in the aged ancy was likely due to the fact that the mice were per-
Figure 6. The Effects of Aging on Phospho-
CREB Immunostaining in the Prefrontal Cor-
tex versus Hippocampus
Images were selected from prefrontal cortex
(PFC) and hippocampal (HIP) (CA3 region) tis-
sues of young versus aged rats that are rep-
resentative of the mean number of cells
observed in Figure 5. The intensity of phos-
pho-CREB immunostaining was consistent
between all animals within a single age group;
i.e., all young animals had light phospho-
CREB staining in prefrontal cortex, while all
aged animals had dark phospho-CREB stain-
ing in prefrontal cortex. Magnification 	200.
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forming a task dependent on the hippocampus, while of age on AC2 and AC3 in the aged prefrontal cortex,
future studies should measure additional AC isoformsthe aged monkeys were performing a task dependent
on the prefrontal cortex. The current results demon- to understand what is causing this PKA overactivation.
It is possible that the activity of other AC isoforms isstrate that indirect activation of the cAMP/PKA intracel-
lular pathway impairs rather than improves the cognitive increased or that there is a loss of some inhibitory com-
ponent in the pathway. Interestingly, AC2, which is un-functioning of the prefrontal cortex in aged monkeys
with prefrontal cortical deficits. Therefore, cAMP/PKA changed with age, is under little inhibitory regulation
and may have the capacity to be superstimulated, e.g.,activation is not an appropriate strategy for treating age-
related cognitive decline. Interestingly, the rolipram by
 subunits (Baker et al., 1999; Iyengar, 1993; Taussig
et al., 1994). Thus, it is plausible that unregulated AC2dose that impaired prefrontal cortical function in our
aged monkeys (10 g/kg) is within the dose range of activity contributes to excessive PKA activity in the aged
prefrontal cortex. Future research may also wish to ex-rolipram tried as an experimental antidepressant in
young adult humans (Zhu et al., 2001). The current data amine age-related changes in other mechanisms that
regulate PKA activity. For example, alterations in thecaution that use of this dose range in elderly humans
may worsen prefrontal cortical regulation of thought and ubiquitin-proteasome cascade, which can lead to per-
sistent PKA activation (Lopez-Salon et al., 2001), mightaffect. Thus, an exclusive focus on hippocampal mecha-
nisms may have hazardous consequences when treat- play a role in this age-related, prefrontal PKA overacti-
vation.ing age-related cognitive decline in humans.
The present study may also explain why 2 adrenergic The disinhibition of PKA signaling in the aged prefron-
tal cortex may also be related to a history of stressagonists are so effective in enhancing prefrontal cortical
cognitive function in aged animals. Studies in both ro- exposure. In young adult animals, acute exposure to
uncontrollable stress rapidly impairs prefrontal corticaldents and monkeys have found that 2 adrenergic ago-
nists improve prefrontal cortical but not nonprefrontal cognitive function, a mechanism that may have survival
value under dangerous conditions (Arnsten, 1998).cortical cognitive functions and that these beneficial
effects become increasingly prominent with advancing Stress-induced prefrontal cortex dysfunction results
from high levels of catecholamine release in the prefron-age (Arnsten and Goldman-Rakic, 1985; Carlson et al.,
1992; Franowicz and Arnsten, 1998; Rama et al., 1996; tal cortex that engage detrimental cAMP/PKA actions
(reviewed in Arnsten, 2000). Glucocorticoids releasedTanila et al., 1996). It is well established that 2 adreno-
ceptors couple to Gi proteins and reduce PKA activation. during stress also impact on prefrontal cortical function.
For example, chronic exposure to high levels of cortico-The current data suggest that aged animals have exces-
sive PKA activity in the prefrontal cortex and thus may sterone induces spine loss from prefrontal cortical neu-
rons in young adult rats (Wellman, 2001), similar to thatshow greater benefit from PKA inhibition via 2 adreno-
ceptor stimulation. observed in aged animals and humans (Feldman and
Dowd, 1975; Page et al., 2002). Given that some ACIn contrast to the prefrontal cortex, hippocampal
memory functions are impaired by stimulation of2 adre- isoforms have been localized to dendritic spines (Mons
et al., 1995), chronic stress exposure may induce archi-noceptors (Tanila, 2001) and enhanced by activation of
the cAMP/PKA pathway. For example, memory consoli- tectural changes that impact on cAMP/PKA signaling.
These data suggest that there may be a relationshipdation and LTP (late phase) depend on activation of
cAMP/PKA signaling (Abel et al., 1997; Barros et al., between stress exposure over the lifespan and disinhibi-
tion of PKA signaling in the aged prefrontal cortex. Infor-2000; Bernabeu et al., 1997; Bourtchouladze et al., 1998;
Frey et al., 1993; Huang and Kandel, 1998; Huang et al., mation regarding the history of stress exposure (e.g.,
subordinate versus dominant relationship with cage2000; Rotenberg et al., 2000; Schafe and LeDoux, 2000).
Thus, changes in the PKA pathway with advancing age in mates) for the aged rats in the current study is not
known. Future research could examine the relationshiphippocampal tissue may contribute to impaired memory
consolidation. Previous studies have shown that for- between a history of stress exposure, disinhibition of
PKA signaling, and erosion of prefrontal cortical cogni-skolin binding is reduced with age in various brain re-
gions including the cerebral cortex and hippocampus, tive function with advancing age.
In summary, the aging process does not effect allsuggesting that the adenylyl cyclase system and thus
the PKA pathway are affected by the aging process brain regions in the same manner. In the hippocampus,
there is a simple reduction in cAMP/PKA signaling with(Araki et al., 1995, 1997). Our results elaborated on these
findings, observing reductions in AC3 levels in the aged advancing age that weakens memory consolidation.
This contrasts with the prefrontal cortex, where advanc-hippocampus. Since adenylyl cyclases are often con-
centrated within spines (Mons et al., 1995) and spines ing age unleashes detrimental PKA actions that impair
working memory. The current study revealed that acti-are lost with age (Page et al., 2002), isoforms such as
AC3 may be in a particularly vulnerable location. How- vating PKA, either directly with Sp-cAMPS or indirectly
with rolipram, exacerbated working memory deficits,ever, it is not yet clear if reduced levels of AC3 contrib-
utes to the decrease in phospho-CREB seen in Figure while PKA inhibition with Rp-cAMPS strengthened work-
ing memory performance. Thus, inhibiting the cAMP/PKA6 (lighter phospho-CREB staining in the aged hippo-
campus). activity appears to be the more appropriate strategy for
treating prefrontal cortical cognitive dysfunction in theSpines are also lost from prefrontal cortical pyramidal
neurons with advancing age (Feldman and Dowd, 1975; elderly. As the prefrontal cortex plays an expansive role
in human cognitive behavior, the distinct neurochemicalPage et al., 2002); thus, slight reductions in AC3 in pre-
frontal cortex may also result from subtle degenerative needs of this cortex must be respected for the develop-
ment of effective cognitive enhancers.processes during aging. Although there was little effect
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Experimental Procedures dissolved in sterile PBS as described previously (Punch et al., 1997).
The experimenter testing the animal was unaware of drug treat-
ment conditions.All procedures were approved by the Yale Institutional Animal Care &
Use Committee. Care of the rats and monkeys followed the guide- Histology
Rats were administered an overdose of ketamine and xylazine andlines in “Guide for the Care and Use of Laboratory Animals.”
sacrificed by decapitation. Brains were removed, stored in formalin,
sectioned, and analyzed for histological verification of cannulae
Rat Studies placement. All rats had correctly placed cannulae (Figure 1).
Subjects Data Analysis
Aged (20 months) and young (9 months) male, retired breeder The relationship between efficacy of Sp-cAMPS or Rp-cAMPS in
Sprague Dawley rats from Harlan (Indianapolis, IN) were single- aged rats versus cognitive status of the aged animals was assessed
housed in filter frame cages. Aged rats were approximately 24 using a Pearson’s r test. The factors were percent correct on the
months old upon initiation of pharmacological testing. Animals were delayed alternation task following drug treatment, versus the num-
kept on a 12 hr light/dark cycle, and experiments were conducted ber of testing sessions required to achieve a 15 s delay. The relation-
during the light phase. Rats were slowly habituated to a restricted ship between the efficacy of Sp-cAMPS versus Rp-cAMPS in the
diet (16 gm/day per rat) of autoclaved Purina (St. Louis, MO) rat same aged rat was also assessed using a Pearson’s r test. The
chow during the first two weeks. Food was given immediately after factors were percent correct on the delayed alternation task follow-
behavioral testing and water was available ad libitum. Rats were ing Sp-cAMPS treatment versus the same animal’s performance
weighed weekly to confirm that they were not undergoing irregular under Rp-cAMPS during a different testing session.
weight loss due to regulated diet. Food rewards during cognitive
testing were highly palatable miniature chocolate chips. Rats were
assigned a single experimenter who handled them extensively be- Monkey Studies
Subjectsfore behavioral testing.
Delayed Alternation in T-Maze The animals used in this study were rhesus monkeys (Macaca mu-
latta) ranging in age from 4 years (postpubescent) to over 30 years.Rats were habituated to a T-maze (dimensions, 90 	 65 cm) until
they were readily eating chocolate chips placed at the end of each Actual birthdates were not available for several of the aged animals
who were wild caught. Ages were estimated by the veterinariansarm and were acclimated to handling. After habituation, rats were
trained on the delayed alternation task. On the first trial, animals based on health records, teeth, and known history; several had been
in the Yale colony for more than 15 years. The young adult monkeyswere rewarded for entering either arm. Thereafter, for a total of 10
trials per session, rats were rewarded only if they entered the maze (4–18 years) consisted of 6 females and 1 male; the aged monkeys
(18–30 years, n 7) were all female. The monkeys were individuallyarm that was not previously chosen. Between trials the choice point
was wiped with alcohol to remove any olfactory clues. The delay housed and maintained on a diet of Purina monkey chow supple-
mented with fruit. Animals were always tested at the same time ofbetween trials started at “0” s (i.e., about 1.5 s, minimum possible
for delayed alternation) and was subsequently raised in 5 s intervals day immediately prior to feeding. Highly palatable food rewards
(e.g., peanuts, raisins, or chocolate chips) were utilized during test-as needed to maintain performance at 60% to 70% correct. Thus,
delay achieved in a set number of testing sessions can be used as ing to minimize the need for dietary regulation.
Delayed Response Testingan index of cognitive ability.
Cannulae Implantation Cognitive testing occurred in a Wisconsin General Testing Appara-
tus (WGTA) situated in a sound-attenuating room. BackgroundAfter training on the delayed alternation task, animals underwent
stereotaxic implantation of chronic guide cannulae as described masking noise (60 dB, wideband) was also used to minimize auditory
distractions. Each monkey was assigned to a single experimenterpreviously (Taylor et al., 1999). Guide cannulae (Plastics One;
2.8 mm) with stylettes were aimed dorsal to the medial prefrontal who knew the animal well but was unaware of the drug treatment
conditions. The animals were tested twice a week with 3–4 dayscortex (prelimbic prefrontal cortex; stereotaxic coordinates: anterio-
posterior, 3.2 mm; mediolateral, 0.75 mm; dorsoventral, stylet separating each test session (e.g., Monday and Thursday). The mon-
keys had been previously trained on the spatial delayed responsereaching to 4.2 mm) as shown in Figure 1. Due to the rats’ age
and fragility, surgery was performed under low doses of a mixture task as described (Arnsten et al., 1988). During delayed response,
the animal watched as the experimenter baited one of several food-of ketamine (80 mg/kg) and xylazine (10 mg/kg) injected (i.p.) prior
to the start of the procedure. These agents were supplemented with wells with a food reward. The number of foodwells varied from two
to four wells, depending on the monkey’s performance level andgas anesthesia (isoflurane) administered during surgery via nose-
cone. Sterile stylets were inserted in the cannula to maintain pat- experience with the task. Care was taken by the experimenter to
ensure that the animal attended the baiting procedure. The food-ency. Great care was taken to minimize pain and infection postoper-
atively to decrease stress to the animal. The region surrounding wells were then covered with identical cardboard plaques, and an
opaque screen was lowered between the animal and the foodwellsthe cemented guide cannula was treated with triple antibiotic and
cleaned daily if needed for a period of about a week. Animals were for a specified delay. At the end of the delay, the screen was raised
and the animal was allowed to choose. Reward was quasi-randomlyalso acutely treated with Buprenex (0.01 mg/kg) to decrease pain.
Drug Infusions distributed between the left and right wells over the 30 trials that
made up a daily test session. Five different delay lengths (referredRats were initially adapted to a mock infusion protocol to minimize
any stress associated with the procedure. Rats were gently re- to as delays A through E) were quasi-randomly distributed over
these 30 trials. The shortest of these delays was less than 1 s (thestrained while the stylets were removed and replaced with 30 gauge
sterile infusion needles that extended to 4.5 mm dorsoventral below “0” s A delay). The remaining delays were in the range that for
each individual monkey yielded baseline performance of about 70%the skull. Bilateral infusions were driven by a Harvard Apparatus
(Hollinston, MA) syringe pump set at a flow rate of 0.25 l/min across all delays (i.e., 18–22 trials correct of the possible 30 trials).
For example, the delays for one animal might be A  0, B  5, C using 25 l Hamilton syringes for an infusion time of 2 min. Needles
remained inserted in place for 2 min after completion of the infusion. 10, D  15, and E  20 s. The “E” delay for the 7 young monkeys
ranged between 20 and 80 s; for the aged monkeys it ranged fromStylets were inserted back into the cannulae, and behavioral testing
was performed immediately after the infusion procedure. Drug treat- 12 to 80 s. Please note that because the monkeys in this study have
participated in research for varying amounts of time (some monkeysments and vehicle were administered in a counterbalanced order
with at least 1 week between each infusion. Counterbalancing en- as long as 15 years, others for only three years), the “delay achieved”
measure cannot be used as an accurate assessment of prefrontalsured that rats received drug infusions both early in the study when
delays were short, as well as later in the study when delays were cortical function in monkeys as it can in rats, who were all tested
for equal amounts of time.longer. Animals were required to exhibit stable baseline perfor-
mance (2 consecutive test sessions of 60%–70% correct) prior to Sedation Assessment
During each cognitive testing session, the experimenter rated thedrug administration. Sp-cAMPS and Rp-cAMPS were purchased
from Sigma RBI (St. Louis, MO). Sp-cAMPS and Rp-cAMPS were animal’s level of sedation/agitation and aggression on rating scales.
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Sedation and agitation were rated using a 9 point scale, where4 of CRE binding were quantified by densitometry. The specificity
of the CRE binding was determined by competition with differenttoo agitated to test,3 agitation that interferes with testing,2
slight agitation that does not interfere with testing, 1  more alert concentrations (3 to 100 ng) of cold CRE, mutated CRE (GATCGGC
TGACGTCTGAG), or human metalliothionein AP-1 oligonucleotides;than usual, 0  normal level of arousal, 1  quieter than usual, 2 
sedated (drooping eyelids, slowed movements), 3  intermittent only unlabeled CRE oligonucleotide effectively competed with la-
beled CRE binding (not shown). For supershift analysis, 1 l of anti-sleeping, and 4  too sedated to test. Aggression was rated using
a similar scale, where 3  dramatically more aggressive, 2  CREB antibody (Upstate) was incubated with cell extracts for 18 hr
at 4C before the addition of the labeled probe. The levels of CREmoderately more aggressive, 1  mildly more aggressive, 0 
normal, 1 mildly less aggressive, 2moderately less aggressive, binding were contrasted between young (9 months) and aged (24
months) rat tissue using unpaired t tests (two-tailed, significanceand 3 dramatically less aggressive.
Drug Administration level  0.05).
Phospho-CREB ImmunohistochemistryRolipram (purchased from Sigma RBI, St. Louis, MO) was dissolved
in 0.2 ml 100% ethanol and 0.8 ml sterile saline and diluted with Young (9 months, n  4) and aged (24 months, n  4) Sprague
Dawley rats were trained on the T-maze task until exhibiting stablesaline to the appropriate concentration for the following doses: 0.01,
0.1, 1.0, 10.0, 50, or 100 g/kg. Drug solutions were made up fresh performance as described above. Each rat was tested on the de-
layed alternation task immediately before sacrifice. Their brains wereeach day under sterile conditions. Drug or vehicle was injected
intramuscularly 1 hr prior to cognitive testing. The order of dose removed and placed in dry ice for subsequent storage at 80C.
Immunohistochemistry for phospho-CREB was performed using aadministration was determined quasi-randomly, and the experi-
menter testing the animal was unaware of the treatment condition. slide-based protocol. Cryocut sections (14 m thick) were briefly
fixed in 4% paraformaldehyde followed by rinses in PBS. This wasA washout period of at least 10 days occurred between drug treat-
ments. Monkeys were required to return to stable baseline perfor- followed by a 5 min treatment with 1% hydrogen peroxide and two
5 min rinses in PBS. Sections were blocked to prevent nonspecificmance for 2 consecutive testing days prior to new drug treatment.
Given these prolonged washout conditions, the research took ap- binding of antibody by a 30 min treatment in a blocking solution
containing 2.5% BSA. Sections were incubated overnight at 4C inproximately 18 months to complete.
Data Analysis antibody solution (0.25% Triton X-100, 1% BSA in PBS) containing
anti-phospho-CREB antibody (Upstate Biotechnology) at 1:2000 di-The rolipram data from young versus aged monkeys were analyzed
using a two-way analysis of variance (2-ANOVA-R) with a within lution. Antibody-treated sections were given three 5 min washes
with PBS to remove unbound primary antibody and were incubatedsubjects factor of rolipram dosage and a between subjects factor
of age. Planned comparison (test of effects) examined the effects in peroxidase-conjugated goat anti-rabbit IgG at 1:400 dilution for
1 hr at room temperature. Unbound secondary antibody was re-of specific rolipram doses versus saline for the young or aged mon-
keys. A more detailed analysis of the effects of 10 g/kg rolipram moved by three 5 min rinses in PBS. Sections were then incubated
in a preformed avidin and biotinylated horseradish peroxidase mac-at each delay interval was performed on the data from the aged
monkeys (2-ANOVA-R; within subjects factors of rolipram and delay romolecular complex (ABC reagent; Vector Labs, Burlingame, CA)
for 1 hr. After this incubation, sections were rinsed three times ininterval). Correlations between estimated age of the monkey and
the response to rolipram were performed using a nonparametric PBS and then stained with the 3,3-diaminobenzidine staining kit
(Vector Labs) according to manufacturer’s directions. Slides wereSpearman test, as actual birthdates were only known for a subset
of animals. air dried, dehydrated in an alcohol series, and coverslipped with
distyrene/plasticizer/xylene mountant. Images of each region were
transferred to a computer program for counting. Cell counts focused
Biochemistry of Rat Brain on the prelimbic region of the prefrontal cortex and the CA3 region
Subjects of hippocampus. The number of cells staining positive for phospho-
Young adult (9 months, n  6) and aged (24 months, n  6) male, CREB was counted in a double-blind fashion by two separate experi-
retired breeder Sprague Dawley rats were purchased from Harlan menters, one unaware of the hypothesis in question. The cell counts
(Indianapolis, IN) and single-housed in filter frame cages under stan- between the two experimenters were in 93.5% agreement. Four
dard laboratory conditions as described above. Aged animals were brain slices were counted for immunopositive cells in each of the
sacrificed by decapitation at the age of 24 months for biochemi- regions examined. The number of cells for each slice was then
cal analysis. averaged and used for statistical analysis using unpaired t tests
Immunoblotting of Adenylyl Cyclase Isoforms and CREB (two-tailed, significance level  0.05).
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